Clinical Trial Update: The Effects of Inositol on Glucose Metabolism in Patients With Metabolic Syndrome at Risk of Cardiac Fibrosis [NA]

View source ↗

Summary

A clinical trial evaluating inositol for glucose metabolism in people with metabolic syndrome at risk of cardiac fibrosis has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Fibrosis
• Metabolic Syndrome

Drugs mentioned

• Inositol (inositol)

Snippet

Sponsor: Lo.Li.Pharma s.r.l | Conditions: Metabolic Syndrome, Cardiac Fibrosis | NA | Status: SUSPENDED